Averothiazide 40 mg/10 mg/12.5 mg 30 tablets

Averothiazide 40 mg/10 mg/12.5 mg 30 tablets

Composition:

Each tablet contains Amlodipine 10 mg,
Hydrochlorothiazide 12.5 mg,
Olmesartan medoxomil 40 mg.

Product Description:

Averothiazide is a fixed‑dose triple combination antihypertensive medication.
It combines a calcium channel blocker, a thiazide diuretic, and an angiotensin II receptor blocker to provide comprehensive blood pressure control.

Indications for Use:

Treatment of essential hypertension in patients whose blood pressure is not adequately controlled with dual therapy.

Method of Administration and Dosage:

Administered orally, one tablet daily, preferably at the same time each day.
Dosage is adjusted according to physician’s prescription and patient’s clinical response.

Contraindications:

Hypersensitivity to amlodipine, hydrochlorothiazide, olmesartan, or excipients.
Pregnancy and lactation.
Severe hypotension, anuria, or advanced renal impairment.
History of angioedema related to ARBs.

Precautions:

Use with caution in patients with hepatic impairment, electrolyte imbalance, or heart failure.
Monitor blood pressure, renal function, and electrolytes during therapy.

Adverse Reactions (Side Effects):

Common: dizziness, headache, ankle edema, fatigue.
Uncommon: rash, gastrointestinal upset, hypotension.
Rare: angioedema, electrolyte disturbances, renal dysfunction.

Pregnancy and Lactation:

Contraindicated during pregnancy and lactation.

Storage Conditions:

Store below 25°C.
Protect from moisture and direct sunlight.

Packaging:

Carton box containing 30 film‑coated tablets, with leaflet.